Yemen’s Chief of Staff to Asharq Al-Awsat: We Received Offers from European Countries for Logistical Support

 L.t Gen. Fahd bin Turki bin Abdulaziz, the commander of the Royal Saudi Ground Forces and Yemeni Chief of Staff Maj. General Taher al-Aqeeli. Saba
L.t Gen. Fahd bin Turki bin Abdulaziz, the commander of the Royal Saudi Ground Forces and Yemeni Chief of Staff Maj. General Taher al-Aqeeli. Saba
TT

Yemen’s Chief of Staff to Asharq Al-Awsat: We Received Offers from European Countries for Logistical Support

 L.t Gen. Fahd bin Turki bin Abdulaziz, the commander of the Royal Saudi Ground Forces and Yemeni Chief of Staff Maj. General Taher al-Aqeeli. Saba
L.t Gen. Fahd bin Turki bin Abdulaziz, the commander of the Royal Saudi Ground Forces and Yemeni Chief of Staff Maj. General Taher al-Aqeeli. Saba

Yemen’s Chief of Staff, Major General Taher Al-Aqeeli, revealed that the Yemeni army has received European and Asian offers to provide logistical support, noting that new agreements would be signed at a later stage for the interest of the army.

In an interview with Asharq Al-Awsat, Al-Aqeeli said that countries in the European Union, Eastern Europe and South-East Asia “expressed they wish to provide logistical support to the army, and there is cooperation with Australia on the maritime side.”

“All the efforts and actions that are currently being implemented are moving towards strengthening of the army to enable it to defend the country, in line with a clear and comprehensive vision… to become a shield for the homeland and the Arab and Islamic nation,” the Yemeni military official said.

“We will work hard to dissolve the tribal authority over the army through the proper establishment of the military institution,” he added.

Al-Aqeeli underlined the role assumed by the Arab coalition in restructuring Yemen’s military institution.

“The Arab coalition forces play an important and pivotal role in all directions, whether with regards to material assistance or advice provided by the coalition leaders to the Yemeni army. We must realize that our brothers in Saudi Arabia and the UAE have not only provided such assistance, but also stood with Yemen in front positions to defend the rights of the Yemeni people,” he stated.

Al-Aqeeli went on to say that the Saudi-led coalition has provided “all possible resources, and harnessed all the tools to serve and develop the army, and the results of this support can be seen on the ground.”

On the liberation of the remaining Yemeni territories, the Chief of Staff noted that the army was moving with accuracy “to reduce the war bill and to save civilian lives on all fronts.”

“Everyone must know that it is difficult to reveal everything, and the army depends on what it does, not what it says… The army will open new fronts, using conventional and traditional tactics in such confrontations, and carry out direct offensive actions,” he said.

Asked about the mechanism to liberate Al-Hodeida port, Al-Aqeeli stressed that plans to regain control over the area were linked to internal and international decisions.

“There will be a joint local, regional and international decision on Hodeida. There will be a move towards the city in time to create a balance on the importance of moving towards Sanaa or Hodeida,” he explained.

Commenting on calls by international organizations to return to dialogue in the wake of the Army’s advancement on the ground, Al-Aqeeli said: “The Iranian project dominates a number of Arab countries… they have exploited the sincerity of international organizations and influenced the public opinion by using these organizations to change the course of events.”

“But days have uncovered to international organizations the Iranian lies,” he added.

On the recent developments following the assassination of former President Ali Abdullah Saleh, the Yemeni chief of staff stressed that the army would carry major operations in coordination with the Arab coalition forces.

“There will be military surprises that will not be disclosed now,” he said. “The army will certainly work in coordination with the Arab coalition forces to take advantage of all the events taking place on the ground in Sanaa.”

He noted that the Yemeni Army has succeeded in attracting leaders and sheikhs from Sanaa to its ranks.

“The army embraces all the Yemeni people from all factions, including scholars, tribes, officials, and therefore it was natural for them to join the army to liberate the remaining cities. We count on them to achieve outstanding results,” he said.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.